Does a Japan-specific rivaroxaban dose demonstrate safety compared to warfarin in Japanese patients with atrial fibrillation?
Japanese patients with atrial fibrillation
Japan-specific rivaroxaban dose
Warfarin
Safetysafety
A Japan-specific dose of rivaroxaban is safe in Japanese patients with atrial fibrillation, supporting the applicability of global ROCKET AF results to this population.
J-ROCKET AF demonstrated the safety of a Japan-specific rivaroxaban dose and supports bridging the global ROCKET AF results into Japanese clinical practice.
Building similarity graph...
Analyzing shared references across papers
Loading...
Masatsugu Hori
Masayasu Matsumoto
Norio Tanahashi
Circulation Journal
Hiroshima University
Tokyo Women's Medical University
Jichi Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
Hori et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69952def9c43653a44f03caf — DOI: https://doi.org/10.1253/circj.cj-12-0454